Standpoint Research downgrades Hansen Natural (Nasdaq: HANS) from Buy to Hold.

Standpoint analyst says, "HANS is ahead of the S&P-500 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE